Biopharma Giant GSK Launches 3rd Chunk Of £2B Buyback
GSK PLC said Tuesday it will reward investors with a share buyback program worth up to £300 million ($403 million), the third part of the British biopharmaceutical giant's £2 billion stock...To view the full article, register now.
Already a subscriber? Click here to view full article